newsfilter
← Latest News
GlobeNewswire·

Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of